Barth Syndrome Latest Advances

Loss of TAFAZZIN leads to perturbation of amino acid metabolism and reduction of collagen synthesis.

Journal: bioRxiv : the preprint server for biology

Published: August 01, 2026

AMCP Market Insights: Managed care considerations in Barth syndrome.

Journal: Journal of managed care & specialty pharmacy

Published: June 26, 2026

Cardiolipin as a Signaling Hub: Evolutionary Conservation and Programmable Platforms Coupling Mitochondrial Stress to Cell Fate.

Journal: International journal of molecular sciences

Published: June 20, 2026

Does the beta subunit of mitochondrial trifunctional protein modulate monolysocardiolipin acylation to cardiolipin?

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: June 05, 2026

Does the beta subunit of mitochondrial trifunctional protein modulate monolysocardiolipin acylation to cardiolipin?

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: June 05, 2026

Elamipretide: a mitochondria-targeting drug for Barth syndrome.

Journal: Trends in pharmacological sciences

Published: May 07, 2026

Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function.

Journal: bioRxiv : the preprint server for biology

Published: April 27, 2026

Clinical development in primary mitochondrial diseases at a translational inflection point: Lessons, mechanisms, and emerging therapeutic strategies.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 21, 2026

Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?

Journal: Cell metabolism

Published: April 18, 2026

Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function.

Journal: The Journal of biological chemistry

Published: April 14, 2026

Role of the Proteasome System in Shaping Cellular Immunological Characteristics and Its Impact in Modulating the Pathogenesis of Immune-Related Diseases.

Journal: Cells, tissues, organs

Published: April 09, 2026

From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial Diseases.

Journal: Clinical and translational science

Published: March 13, 2026

Barth Syndrome Latest Advances

Find the Latest Research About Barth Syndrome

Loss of TAFAZZIN leads to perturbation of amino acid metabolism and reduction of collagen synthesis.

Loss of TAFAZZIN leads to perturbation of amino acid metabolism and reduction of collagen synthesis.

AMCP Market Insights: Managed care considerations in Barth syndrome.

AMCP Market Insights: Managed care considerations in Barth syndrome.

Cardiolipin as a Signaling Hub: Evolutionary Conservation and Programmable Platforms Coupling Mitochondrial Stress to Cell Fate.

Cardiolipin as a Signaling Hub: Evolutionary Conservation and Programmable Platforms Coupling Mitochondrial Stress to Cell Fate.

Does the beta subunit of mitochondrial trifunctional protein modulate monolysocardiolipin acylation to cardiolipin?

Does the beta subunit of mitochondrial trifunctional protein modulate monolysocardiolipin acylation to cardiolipin?

Does the beta subunit of mitochondrial trifunctional protein modulate monolysocardiolipin acylation to cardiolipin?

Does the beta subunit of mitochondrial trifunctional protein modulate monolysocardiolipin acylation to cardiolipin?

Elamipretide: a mitochondria-targeting drug for Barth syndrome.

Elamipretide: a mitochondria-targeting drug for Barth syndrome.

Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function.

Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function.

Clinical development in primary mitochondrial diseases at a translational inflection point: Lessons, mechanisms, and emerging therapeutic strategies.

Clinical development in primary mitochondrial diseases at a translational inflection point: Lessons, mechanisms, and emerging therapeutic strategies.

Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?

Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?

Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function.

Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function.

Role of the Proteasome System in Shaping Cellular Immunological Characteristics and Its Impact in Modulating the Pathogenesis of Immune-Related Diseases.

Role of the Proteasome System in Shaping Cellular Immunological Characteristics and Its Impact in Modulating the Pathogenesis of Immune-Related Diseases.

From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial Diseases.

From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial Diseases.